Literature DB >> 27457085

Is Heart Rate a Norepiphenomenon in Heart Failure?

Mark Hensey1, James O'Neill2.   

Abstract

There has been an increased focus on heart rate as a target in the management of cardiovascular disease and more specifically in heart failure with preserved ejection fraction in recent years with several studies showing the benefit of a lower resting heart rate on outcomes. This review paper examines the pathophysiology behind the benefits of lowering heart rate in heart failure and also the evidence for and against the pharmacological agents available to achieve this.

Entities:  

Keywords:  Heart failure; Heart rate; Norepiphenomenon

Mesh：

Substances：

Year:  2016        PMID： 27457085     DOI： 10.1007/s11886-016-0764-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  59 in total

1.  Ivabradine in heart failure: to SHIFT or not to SHIFT.

Authors:  Andres Schuster; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2011-03

Review 2.  Adrenergic nervous system in heart failure.

Authors:  M Esler; D Kaye; G Lambert; D Esler; G Jennings
Journal:  Am J Cardiol       Date:  1997-12-04       Impact factor: 2.778

Review 3.  Rest heart rate and life expectancy.

Authors:  H J Levine
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

4.  Effect of nesiritide in patients with acute decompensated heart failure.

Authors:  C M O'Connor; R C Starling; A F Hernandez; P W Armstrong; K Dickstein; V Hasselblad; G M Heizer; M Komajda; B M Massie; J J V McMurray; M S Nieminen; C J Reist; J L Rouleau; K Swedberg; K F Adams; S D Anker; D Atar; A Battler; R Botero; N R Bohidar; J Butler; N Clausell; R Corbalán; M R Costanzo; U Dahlstrom; L I Deckelbaum; R Diaz; M E Dunlap; J A Ezekowitz; D Feldman; G M Felker; G C Fonarow; D Gennevois; S S Gottlieb; J A Hill; J E Hollander; J G Howlett; M P Hudson; R D Kociol; H Krum; A Laucevicius; W C Levy; G F Méndez; M Metra; S Mittal; B-H Oh; N L Pereira; P Ponikowski; W H W Tang; W H Wilson; S Tanomsup; J R Teerlink; F Triposkiadis; R W Troughton; A A Voors; D J Whellan; F Zannad; R M Califf
Journal:  N Engl J Med       Date:  2011-07-07       Impact factor: 91.245

5.  Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

Authors: 
Journal:  Am J Cardiol       Date:  1990-10-01       Impact factor: 2.778

6.  Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry.

Authors:  Nish Patel; Christine Ju; Conrad Macon; Udho Thadani; Phillip J Schulte; Adrian F Hernandez; Deepak L Bhatt; Javed Butler; Clyde W Yancy; Gregg C Fonarow
Journal:  JACC Heart Fail       Date:  2016-02-10       Impact factor: 12.035

7.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Authors:  Marcus D Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J Van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jiri Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Journal:  Eur Heart J       Date:  2005-01-09       Impact factor: 29.983

Review 8.  Ventricular remodeling in heart failure and the effect of beta-blockade.

Authors:  James E Udelson
Journal:  Am J Cardiol       Date:  2004-05-06       Impact factor: 2.778

9.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

10.  Beta-blockers influence the short-term and long-term prognostic information of natriuretic peptides and catecholamines in chronic heart failure independent from specific agents.

Authors:  Lutz Frankenstein; Manfred Nelles; Maxim Slavutsky; Dieter Schellberg; Andreas Doesch; Hugo Katus; Andrew Remppis; Christian Zugck
Journal:  J Heart Lung Transplant       Date:  2007-10       Impact factor: 10.247
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.